Ticker Launch

SPAC · Merger completed

Montes Archimedes Acquisition Corp

Business combination with Roivant Sciences Ltd.

Montes Archimedes Acquisition Corp is a blank-check company (SPAC) that raised $400M in its initial public offering on Oct 9, 2020, listing on Nasdaq Capital Market. It completed its business combination with Roivant Sciences Ltd. on Sep 30, 2021; the combined company is Roivant Sciences Ltd. (ROIV). Kirkland & Ellis advised the SPAC and Ropes & Gray advised the underwriters on the IPO.

Roivant Sciences Ltd. develops medicines by building technologies and talent and launching Vants, which are focused biopharmaceutical and health technology companies. It is the target of a business combination with Montes Archimedes Acquisition Corp.

Status
Merger completed
IPO date
Oct 9, 2020
IPO size
$400M
IPO exchange
Nasdaq Capital Market
Target
Roivant Sciences Ltd.
Announced
May 3, 2021
Closed
Sep 30, 2021
Combined company
Roivant Sciences Ltd. (ROIV)
SPAC counsel (IPO)
Kirkland & Ellis
Underwriters' counsel (IPO)
Ropes & Gray

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021